The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joly, P.
Right arrow Articles by Autran, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joly, P.
Right arrow Articles by Autran, B.

The Journal of Immunology, Vol 143, Issue 7 2193-2201, Copyright © 1989 by American Association of Immunologists


ARTICLES

Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes

P Joly, JM Guillon, C Mayaud, F Plata, I Theodorou, M Denis, P Debre and B Autran
Laboratoire d'Immunologie Cellulaire et Tissulaire, UA CNRS 0186, Paris, France.

CTL specific for HIV have been described in lungs of infected patients at early stages of HIV disease. In order to characterize the evolution over time of HIV-specific CTL, we have analyzed the cytotoxic function and the cell surface phenotype of the alveolar lymphocytes from 41 patients at various stages of HIV disease. We demonstrated a progressive decline of alveolar anti-HIV CTL activity and detected Ts cells from the lungs of patients with advanced HIV disease. These alveolar T cells strongly suppressed the effector phase of anti-HIV CTL lysis. They lacked a marked specificity of function because they also block anti-HLA CTL response and were not restricted by the HLA-class-I transplantation Ag. They displayed the CD3, CD8, and HNK1 markers, were CD4 and CD16 negative, and lacked NK activity. The presence of Ts cells at late stages of HIV disease could thus partly explain the inefficiency of host defenses against HIV.


This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Le Priol, D. Puthier, C. Lecureuil, C. Combadiere, P. Debre, C. Nguyen, and B. Combadiere
High Cytotoxic and Specific Migratory Potencies of Senescent CD8+CD57+ Cells in HIV-Infected and Uninfected Individuals
J. Immunol., October 15, 2006; 177(8): 5145 - 5154.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Nitcheu, O. Bonduelle, C. Combadiere, M. Tefit, D. Seilhean, D. Mazier, and B. Combadiere
Perforin-Dependent Brain-Infiltrating Cytotoxic CD8+ T Lymphocytes Mediate Experimental Cerebral Malaria Pathogenesis
J. Immunol., February 15, 2003; 170(4): 2221 - 2228.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. L. Garba, C. D. Pilcher, A. L. Bingham, J. Eron, and J. A. Frelinger
HIV Antigens Can Induce TGF-{beta}1-Producing Immunoregulatory CD8+ T Cells
J. Immunol., March 1, 2002; 168(5): 2247 - 2254.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Fiorentini, S. Licenziati, G. Alessandri, F. Castelli, S. Caligaris, M. Bonafede, M. Grassi, E. Garrafa, A. Balsari, A. Turano, et al.
CD11b Expression Identifies CD8+CD28+ T Lymphocytes with Phenotype and Function of Both Naive/Memory and Effector Cells
J. Immunol., January 15, 2001; 166(2): 900 - 907.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. L. TWIGG III, D. M. SOLIMAN, R. B. DAY, K. S. KNOX, R. J. ANDERSON, D. S. WILKES, and C. T. SCHNIZLEIN-BICK
Lymphocytic Alveolitis, Bronchoalveolar Lavage Viral Load, and Outcome in Human Immunodeficiency Virus Infection
Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1439 - 1444.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. N. Posnett, J. W. Edinger, J. S. Manavalan, C. Irwin, and G. Marodon
Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+CD28– cytotoxic effector clones
Int. Immunol., February 1, 1999; 11(2): 229 - 241.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. L. Twigg III, B. A. Spain, D. M. Soliman, K. Knox, R. A. Sidner, C. Schnizlein-Bick, D. S. Wilkes, and G. K. Iwamoto
Production of interferon-gamma by lung lymphocytes in HIV-infected individuals
Am J Physiol Lung Cell Mol Physiol, February 1, 1999; 276(2): L256 - L262.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
F. Hadida, V. Vieillard, B. Autran, I. Clark-Lewis, M. Baggiolini, and P. Debre
HIV-specific T Cell Cytotoxicity Mediated by RANTES Via the Chemokine Receptor CCR3
J. Exp. Med., August 3, 1998; 188(3): 609 - 614.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.